When a candidate variant tracks with a disorder through a family, that pattern can support a causal hypothesis. The strength of that support depends on how informative the family is. Several relatives with the same common symptom do not automatically provide strong evidence, and a clinically unaffected carrier does not always refute a disease association.

Illustrated overview of what family data can establish, highlighting informative relatives, inheritance pattern, evidence limits.
What family data can establish: informative relatives, inheritance pattern, evidence limits. Read the article for evidence and limitations. Original conceptual illustration.

Establish what is segregating

ClinGen’s guidance on PP1, BS4 and phenotype specificity explains how segregation evidence relates to a locus and how it can overlap with other evidence. Two variants on the same inherited allele may travel together. Observing that allele in affected relatives does not, by itself, identify which variant is responsible. Counting both as independently proven would overstate the result. Read the ClinGen segregation guidance.

The pedigree should show confirmed relationships, relevant genotypes and how affected status was determined. Keep the proband distinct from additional informative family observations. For recessive disorders, establish phase when required: two variants in one gene may lie together on one chromosome rather than on opposite copies.

Define the phenotype before counting

The ClinGen familial hypercholesterolemia expert-panel specifications illustrate why disease-specific definitions matter. Their approach uses carefully defined lipid phenotypes and addresses the influence of treatment. Those criteria are an example of tailored guidance, not a formula to reuse for unrelated disorders. An imprecise designation of affected or unaffected can be more damaging than a small pedigree. Read the LDLR expert-panel specifications.

Editorial illustration: Three family members placing distinct inheritance-result cards side by side while a counsellor identifies one informative comparison.
Conceptual illustration accompanying this article. People and situations depicted are fictional; this is not a diagnostic image.

Age-dependent onset, reduced penetrance, variable expression and phenocopies can all complicate interpretation. An apparently unaffected relative may be too young, incompletely assessed, or treated in a way that obscures a characteristic feature. Conversely, an affected noncarrier may have a different cause for a superficially similar presentation.

Use the study to answer a defined question

  • State which relatives would provide informative evidence and why.
  • Record relevant negative findings and the age of assessment.
  • Avoid counting overlapping family and phenotype evidence twice.
  • Apply current gene-specific specifications where appropriate.

Large or complex pedigrees may need formal analysis rather than a simple count. The resulting conclusion should describe the evidence gained and its limitations. Family testing can clarify a variant, but its diagnostic usefulness depends on the biological question and the quality of clinical information accompanying each sample.